These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3912090)

  • 1. [Stimulation of insulin secretion by ambenonium chloride (Mytelase)].
    Sunada Y; Tamaoka A; Takeda K; Mannen T
    Rinsho Shinkeigaku; 1985 Sep; 25(9):1033-8. PubMed ID: 3912090
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary spastic angina induced by anticholinesterase medication for myasthenia gravis--a case report.
    Suzuki M; Yoshii T; Ohtsuka T; Sasaki O; Hara Y; Okura T; Shigematsu Y; Hamada M; Hiwada K
    Angiology; 2000 Dec; 51(12):1031-4. PubMed ID: 11132996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic studies of ambenonium chloride in patients with myasthenia gravis.
    Tharasse-Bloch C; Chabenat C; Boucly P; Marchand J; Elkharrat D; Boucly-Goester C; Gajdos P
    Eur J Drug Metab Pharmacokinet; 1991; 16(4):299-303. PubMed ID: 1823874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative care after thymectomy for myasthenia gravis.
    Prazák M; Placák B
    Int Surg; 1969 May; 51(5):388-94. PubMed ID: 5781286
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current treatment of myasthenia gravis].
    de Assis JL
    Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapetic measures in myasthenia gravis].
    Cavaciuti P; Gatti E
    Minerva Anestesiol; 1969 Aug; 35(8):765-79. PubMed ID: 5364124
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the treatment of myasthenia].
    Delwaide JP
    Rev Med Liege; 1968 Sep; 23(18):552-7. PubMed ID: 4316587
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of pseudoparalytic myasthenia gravis].
    Fasshauer K
    Dtsch Med Wochenschr; 1975 Oct; 100(44):2283-4. PubMed ID: 1183327
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of food on serum ambenonium concentration in patients with myasthenia gravis.
    Ohtsubo K; Fujii N; Higuchi S; Aoyama T; Goto I; Tatsuhara T
    Eur J Clin Pharmacol; 1992; 42(4):371-4. PubMed ID: 1516600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of myasthenia gravis in pregnancy].
    Pezzoli G; Bonfadini Bossi E; Rella R
    Minerva Ginecol; 1980; 32(1-2):21-6. PubMed ID: 6245392
    [No Abstract]   [Full Text] [Related]  

  • 11. [Case of severe amyosthenia].
    Inokawa H; Zenda Y; Honda S; Kawasaki T; Okamura Y
    Naika; 1966 Apr; 17(4):789-92. PubMed ID: 5960836
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acute postpartum complications in myasthenia].
    Beyer L; Seitz D
    Dtsch Z Nervenheilkd; 1965 Aug; 187(5):527-30. PubMed ID: 5320099
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of ambenonium (mysuran) chloride.
    WESTERBERG MR
    AMA Arch Neurol Psychiatry; 1956 Jan; 75(1):91-4. PubMed ID: 13275166
    [No Abstract]   [Full Text] [Related]  

  • 14. Sensitive determination of ambenonium chloride in serum from patients with myasthenia gravis using ion-exchange resin extraction and reversed-phase ion-pair chromatography.
    Ohtsubo K; Higuchi S; Aoyama T; Fujii N; Goto I
    J Chromatogr; 1989 Nov; 496(2):397-406. PubMed ID: 2613842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MYASTHENIA GRAVIS].
    VAN HOVE
    Belg Tijdschr Geneesk; 1965 Jan; 21():81-4. PubMed ID: 14273382
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
    Kunze K
    Med Klin; 1973 Jun; 68(22):723-30. PubMed ID: 4715780
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current trends in medical and surgical treatment of myasthenia gravis with persistence of the thymus and long-term results of some operated cases].
    Sunseri S; Sottosanti M; Spinelli P
    Arch Chir Torac Cardiovasc; 1970; 26(1):19-34. PubMed ID: 5477673
    [No Abstract]   [Full Text] [Related]  

  • 18. [Episodes of clinical manifestations referable to probable involvement of the immune system in 2 sisters with myasthenia gravis].
    Casirola G; Marini G; Ippoliti G
    Minerva Med; 1974 Jul; 65(52):2815-7. PubMed ID: 4367756
    [No Abstract]   [Full Text] [Related]  

  • 19. [The treatment with ambenonium chloride (Mytelase) in weakness of accommodation and accommodative asthenopia].
    TANABE Y
    Rinsho Ganka; 1961 Jul; 15():836-8. PubMed ID: 13919451
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current therapy of myasthenia gravis. I. Specific symptomatic therapy].
    Erbslöh F
    Nervenarzt; 1972 Jul; 43(7):341-4. PubMed ID: 4627866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.